For Investors & Institutional Partners

Trusted structure for allied defense innovation.

Access a qualified pipeline of allied defense technologies supported by originator diligence, IP and structure review, U.S. market preparation, manufacturing-readiness analysis, customer-pathway development, and experienced operator judgment.

Helicon Defense is building the operating discipline that lets serious capital deploy into allied defense innovation with confidence.

  • 2 hard-tech companies led to acquisition
  • 125+ issued patents worldwide
  • 200+ person production organization built (Nuvotronics)
  • AS9100D manufacturing history
  • Direct-to-prime defense experience
Why this market exists now

Allied defense innovation has outpaced the structures that make it investable.

The last three years have generated more operationally validated defense technology across allied nations than the previous decade. Ukrainian founders, in particular, have developed capability that meets a real warfighter problem under conditions that no test range can replicate.

The gap is not talent, nor technical merit, nor market demand. The gap is the missing operating layer between demonstrated capability and the trusted U.S. and allied structure that lets institutional capital deploy, that lets defense customers procure, and that lets manufacturing partners commit. Helicon exists to build that layer.

Why promising technologies remain uninvestable

Strong technology inside weak structure is not investable.

Institutional capital doing meaningful diligence looks first at people, then at the structure around the technology. Ukrainian and allied founders arriving in international markets frequently confront the same set of structural obstacles:

  • No U.S. or allied entity that a serious investor can back — foreign-domiciled companies with unclear IP chain of custody, uncertain export posture, and no U.S. operating footprint.
  • IP structures that do not withstand institutional diligence — background IP unclear, licensing ambiguous, originator equity vulnerable to dilution or forced disclosure.
  • No trusted manufacturing pathway — production concentrated in a wartime environment, with no U.S. or allied supply chain, no quality system, and no scale plan.
  • No credible U.S. or allied customer pathway — battlefield validation does not automatically translate into a U.S. program of record, a prime contractor relationship, or an acquisition vehicle.
  • Founder profile misaligned to institutional expectations — brilliant technical operators without the U.S. commercial, legal, and compliance overlay that institutional capital requires.

None of these are technology problems. They are structure problems. That is what Helicon operates.

What Helicon does to reduce risk

Six discipline layers between capability and capital.

Helicon reduces technical, structural, manufacturing, compliance, and market risk across a defined operating discipline. Each layer is a real capability, not a promise.

01

Technology & founder diligence

Independent technical validation, founder assessment, IP chain-of-custody review, and readiness-level analysis against a real warfighter problem.

02

U.S. structure & capital readiness

Entity architecture, licensing structure, IP protection, U.S. operating footprint, and the corporate discipline that institutional capital expects at diligence.

03

Protected IP & commercialization

Background-IP preservation, foreground-IP structuring, licensing pathways, export/import compliance, and originator equity protection.

04

Manufacturing & scale-up assessment

MRL analysis, trusted supply-chain pathway, U.S. or allied production planning, and integration with real hard-tech operating infrastructure.

05

Defense-market & acquisition context

Alignment of the capability to a real service partner, budget line, and acquisition pathway — from SBIR/STTR and OTA through program-of-record placement and sustainment.

06

Operator judgment

The judgment of a repeat hard-tech founder who has moved DARPA-funded technology to acquired outcomes twice, and who has stood up production-grade quality systems that serve primes.

How the economics work

One transition can create value more than once.

Helicon is designed as a repeatable transition platform, not a single-product company. A serious allied technology carried through the transition layer can generate value in more than one way. The architecture is deliberately structured so that value can be earned at several stages of a technology's transition — from early qualification through licensing, production, and long-tail sustainment.

Revenue layer Who typically pays What Helicon delivers Timing
1. Qualification & transition fees Originator, sponsor, strategic partner, or program customer Diligence, capability framing, IP and compliance sequencing, transition plan Near-term
2. Demonstration & program revenue Government customer, prime, integrator, or program sponsor Test plans, prototypes, demonstrations, evaluation packages, program execution Near- to mid-term
3. Licensing economics U.S./allied licensee, integrator, manufacturer, or end customer Exclusive or field-limited commercialization rights and protected technology transfer Mid- to long-term
4. Manufacturing & integration margin Prime, program office, allied buyer, or channel partner Trusted localization, low-rate production, integration, quality, supply chain, and sustainment Mid-term
5. Equity or enterprise participation Portfolio company or structured transition vehicle Capital, U.S. formation, operating support, market access, and transition execution Long-term
6. Sustainment & lifecycle revenue Operator, buyer, integrator, or program Spares, upgrades, training, repair, software and support, configuration and supply-chain continuity Recurring

The model is a portfolio, not a single bet.

The advantage is a repeatable selection-and-transition system applied across multiple allied technologies. Because value can be created at more than one layer per transition, a disciplined portfolio can combine early service and program revenue with later licensing, production, sustainment, and enterprise-value outcomes across several technologies at different maturities.

How Helicon itself charges.

  • Advisory and structuring engagements are scoped and priced by the discipline layers involved.
  • Equity participation, when appropriate, is structured to align Helicon with the long-term success of the originator company.
  • Referral and introduction arrangements are declared in writing to all parties.
  • Helicon does not accept success fees on capital-raise activity that would require broker-dealer registration Helicon does not hold.

The layers described above are the architecture of the model. Specific arrangements vary by engagement and by portfolio company. This page is informational. Nothing on this page is an offer to sell or a solicitation to buy any security. Helicon Defense is not a broker-dealer, investment adviser, or placement agent. Engagements are structured with qualified counsel appropriate to the parties and jurisdictions involved.

Helicon Perspective

Trusted transition infrastructure is where the enterprise value is.

The $200,000 answer to a $2,000 threat is not a strategy. Neither is a great technology stranded inside a structure no one can back.

The next generation of allied defense capability will not be defined by who has the cleverest prototype. It will be defined by who owns the trusted operating layer that turns cleverness into fielded capability at the speed democracies need.

That layer is what Helicon is building. It is a company thesis, not a slogan — and the enterprise value follows the discipline.

Start a protected conversation

How to begin.

Helicon routes investor and institutional-partner conversations through a protected intake so we can respect the confidentiality of what you are exploring and match you to the correct next step. Please describe your organization and interest in non-confidential terms.

Do not include confidential deal terms, non-public financial information, or controlled technical data in the first message. Initial intake is limited to non-confidential descriptions of interest.